The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
Abstract
Background—: Drug-eluting stents (DES) have been in clinical use for nearly a decade; however, the relative short- and long-term efficacy and safety of DES compared with bare-metal stents (BMS) and among the DES types are less well defined. Methods and Results—: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for randomized clinical trials, until March 2012, that compared any of the Food and Drug Administration–approved durable stent and polymer DES (sirolimus-eluting stent [SES], paclitaxel-eluting stent [PES], everolimus-eluting stent [EES], zotarolimus-eluting stent [ZES], and ZES-Resolute [ZES-R]) with each other or against BMS for de novo coronary lesions, enrolling at least 100 patients and with follow-up of at least 6 months. Short-term (≤1 year) and long-term efficacy (target-vessel revascularization, target-lesion revascularization) and safety (death, myocardial infarction, stent thrombosis) outcomes were evaluated and trial-level data pooled by both mixed-treatment comparison and direct comparison analyses. From 76 randomized clinical trials with 117 762 patient-years of follow-up, compared with BMS, each DES reduced long-term target-vessel revascularization (39%–61%), but the magnitude varied by DES type (EES∼SES∼ZES-R>PES∼ZES>BMS), with a >42% probability that EES had the lowest target-vessel revascularization rate. There was no increase in the risk of any long-term safety outcomes, including stent thrombosis, with any DES (versus BMS). In addition, there was reduction in myocardial infarction (all DES except PES versus BMS) and stent thrombosis (with EES versus BMS: Rate ratio, 0.51; 95% credibility interval, 0.35–0.73). The safest DES appeared to be EES (>86% probability), with reduction in myocardial infarction and stent thrombosis compared with BMS. Short-term outcomes were similar to long-term outcomes, with SES, ZES-R, and everolimus-eluting stent being the most efficacious and EES being the safest stent. Conclusions—: DES are highly efficacious at reducing the risk of target-vessel revascularization without an increase in any safety outcomes, including stent thrombosis. However, among the DES types, there were considerable differences, such that EES, SES, and ZES-R were the most efficacious and EES was the safest stent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Self-citationA Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Combination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,656
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
Stone, G. W., Sabik, J. F., Serruys, P. W., Simonton, C. A., Généreux, P., Puskas, J., Kandzari, D. E., Morice, M.-C., Lembo, N., Brown, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610227 · Cited by 1,068
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
Stone, G. W., Kappetein, A. P., Sabik, J. F., Pocock, S. J., Morice, M.-C., Puskas, J., Kandzari, D. E., Karmpaliotis, D., Brown, W. M., Lembo, N. J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1909406 · Cited by 797
Drug-Eluting Coronary-Artery Stents
Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 728
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Ellis, S. G., Kereiakes, D. J., Metzger, D. C., Caputo, R. P., Rizik, D. G., Teirstein, P. S., Litt, M. R., Kini, A., Kabour, A., Marx, S. O., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509038 · Cited by 630
Feres, F. (2013) · JAMA · doi:10.1001/jama.2013.282183 · Cited by 589
Intravascular Imaging–Guided or Angiography-Guided Complex PCI
Lee, J. M., Choi, K. H., Song, Y. B., Lee, J.-Y., Lee, S.-J., Lee, S. Y., Kim, S. M., Yun, K. H., Cho, J. Y., Kim, C. J., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2216607 · Cited by 572
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
Bønaa, K. H., Mannsverk, J., Wiseth, R., Aaberge, L., Myreng, Y., Nygård, O., Nilsen, D. W., Kløw, N.-E., Uchto, M., Trovik, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607991 · Cited by 553
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
Park, S.-J., Ahn, J.-M., Kim, Y.-H., Park, D.-W., Yun, S.-C., Lee, J.-Y., Kang, S.-J., Lee, S.-W., Lee, C. W., Park, S.-W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415447 · Cited by 505
Otsuka, F., Vorpahl, M., Nakano, M., Foerst, J., Newell, J. B., Sakakura, K., Kutys, R., Ladich, E., Finn, A. V., Kolodgie, F. D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.001790 · Cited by 491
Long-Term Safety of Drug-Eluting and Bare-Metal Stents
Palmerini, T., Benedetto, U., Biondi-Zoccai, G., Della Riva, D., Bacchi-Reggiani, L., Smits, P. C., Vlachojannis, G. J., Jensen, L. O., Christiansen, E. H., Berencsi, K., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.017 · Cited by 470
Sabate, M., Cequier, A., Iñiguez, A., Serra, A., Hernandez-Antolin, R., Mainar, V., Valgimigli, M., Tespili, M., den Heijer, P., Bethencourt, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61223-9 · Cited by 462
Smilowitz, N. R., Gupta, N., Ramakrishna, H., Guo, Y., Berger, J. S., & Bangalore, S. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4792 · Cited by 451
Self-citationCassese, S., Byrne, R. A., Tada, T., Pinieck, S., Joner, M., Ibrahim, T., King, L. A., Fusaro, M., Laugwitz, K.-L., & Kastrati, A. (2014) · Heart · doi:10.1136/heartjnl-2013-304933 · Cited by 438
Self-citation2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
Witzenbichler, B., Maehara, A., Weisz, G., Neumann, F.-J., Rinaldi, M. J., Metzger, D. C., Henry, T. D., Cox, D. A., Duffy, P. L., Brodie, B. R., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003942 · Cited by 408
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S., Bøtker, H. E., De Hert, S., Ford, I., Juanatey, J. R. G., Gorenek, B., Heyndrickx, G. R., et al. (2014) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000150 · Cited by 408
Gilard, M., Barragan, P., Noryani, A. A. L., Noor, H. A., Majwal, T., Hovasse, T., Castellant, P., Schneeberger, M., Maillard, L., Bressolette, E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.008 · Cited by 360
Siontis, G. C. M., Stefanini, G. G., Mavridis, D., Siontis, K. C., Alfonso, F., Pérez-Vizcayno, M. J., Byrne, R. A., Kastrati, A., Meier, B., Salanti, G., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60657-2 · Cited by 349
Serruys, P. W., Farooq, V., Kalesan, B., de Vries, T., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F., Wijns, W., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.011 · Cited by 331
Navarese, E. P., Andreotti, F., Schulze, V., Ko odziejczak, M., Buffon, A., Brouwer, M., Costa, F., Kowalewski, M., Parati, G., Lip, G. Y. H., et al. (2015) · BMJ · doi:10.1136/bmj.h1618 · Cited by 330
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography
Taniwaki, M., Radu, M. D., Zaugg, S., Amabile, N., Garcia-Garcia, H. M., Yamaji, K., Jørgensen, E., Kelbæk, H., Pilgrim, T., Caussin, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019071 · Cited by 327
Palmerini, T., Biondi-Zoccai, G., Della Riva, D., Mariani, A., Sabaté, M., Smits, P. C., Kaiser, C., D'Ascenzo, F., Frati, G., Mancone, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.061 · Cited by 313
Bangalore, S., Toklu, B., Amoroso, N., Fusaro, M., Kumar, S., Hannan, E. L., Faxon, D. P., & Feit, F. (2013) · BMJ · doi:10.1136/bmj.f6625 · Cited by 310
Self-citationBangalore, S., Toklu, B., Patel, N., Feit, F., & Stone, G. W. (2018) · Circulation · doi:10.1161/circulationaha.118.034456 · Cited by 309
Self-citationKandzari, D. E., Mauri, L., Koolen, J. J., Massaro, J. M., Doros, G., Garcia-Garcia, H. M., Bennett, J., Roguin, A., Gharib, E. G., Cutlip, D. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32249-3 · Cited by 279
Alfonso, F., Pérez-Vizcayno, M. J., Cárdenas, A., García del Blanco, B., Seidelberger, B., Iñiguez, A., Gómez-Recio, M., Masotti, M., Velázquez, M. T., Sanchís, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.006 · Cited by 269
Pilgrim, T., Heg, D., Roffi, M., Tüller, D., Muller, O., Vuilliomenet, A., Cook, S., Weilenmann, D., Kaiser, C., Jamshidi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61038-2 · Cited by 267
Stone, G. W., Gao, R., Kimura, T., Kereiakes, D. J., Ellis, S. G., Onuma, Y., Cheong, W.-F., Jones-McMeans, J., Su, X., Zhang, Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01039-9 · Cited by 266
New concepts in the design of drug-eluting coronary stents
Garg, S., Bourantas, C., & Serruys, P. W. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.13 · Cited by 125
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease
Abdallah, M. S., Wang, K., Magnuson, E. A., Osnabrugge, R. L., Kappetein, A. P., Morice, M.-C., Mohr, F. A., Serruys, P. W., & Cohen, D. J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.031 · Cited by 82
Zhang, X.-L., Zhu, L., Wei, Z.-H., Zhu, Q.-Q., Qiao, J.-Z., Dai, Q., Huang, W., Li, X.-H., Xie, J., Kang, L.-N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0006 · Cited by 31
Metadata
- Authors
- Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M. J., Feit, F., Bhatt, D. L., & Slater, J.
- Venue
- Circulation
- Published
- 2012-06-12
- Volume
- 125
- Issue
- 23
- Pages
- 2873-2891
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2046209971
- Cited by
- 574
- References
- 78
- FWCI
- 70.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.